📰 Psychedelics News
Curated updates on microdosing, research, policy, and community.
Filters
Psychedelic Science 2025
Psychedelic Science 2025 is the world’s largest gathering focused on psychedelic research, policy, therapy, and culture. Hosted in Denver, Colorado, this landmark event brings together leading scientists, therapists, ...
Oakland Psychedelic Conference
Oakland Hosts Historic Psychedelic and Spirituality Gathering This Weekend This weekend, Oakland becomes the epicenter of psychedelic and spiritual exploration with the two-day event: Oakland ...
Kayse Gehret – The Modern Guide: Microdosing, Facilitation & Community
In this episode, Kyle Buller speaks with Kayse Geheret, founder of Microdosing for Healing and instructor for Psychedelics Today’s Vital program. They explore what it means to be a modern guide in the world of psyched...
LSD analogue with potential for treating schizophrenia developed
Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.
Saturday Day tickets now on sale!
And, Saturday night accommodation discount!!!
100+ speakers confirmed for Breaking Convention 2025!
Names and talk titles for your delight
Correcting the Record: Addressing The New York Times’ Deceptive Coverage of Psymposia
Rather than unpacking the actual causes of Lykos Therapeutics' disastrous Phase 3 trials and FDA rejection, The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public ...
Correcting the Record: What The New York Times Got Wrong
In response to the The New York Times February 4 article, "How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy," Psymposia requested corrections to numerous errors and false accusations. The po...
Compound harnesses cannabis' pain-relieving properties without side effects
Researchers have developed a compound that relieves pain in mice but doesn't affect the brain, thereby avoiding mind-altering side effects and abuse potential. The custom-designed molecule, derived from cannabis, may ...
Only 46 days until Breaking Convention 2025!!!
Last few on-campus accommodation rooms remaining
Our favorite investable areas in brain health with PsyMed Ventures
Greg and Matias chat with Brooks about the evolution of PsyMed Ventures’ investment strategy: a human-first approach to neurotech, novel therapeutics, consumer health, and precision neuroscience
Researchers achieve total synthesis of ibogaine
Researchers have achieved total chemical synthesis of the psychoactive compound ibogaine and its analogs from pyridine. The discovery will make it easier to explore the therapeutic possibilities of ibogaine.
Temporal Interference: The Future of Brain Stimulation with Nir Grossman
Business Trip by PsyMed Ventures, a podcast exploring the future of mental and brain health & the startups building it
This is your last call to take part in Europe's largest multidisciplinary conference on psychedelics!
DEADLINE 19th January!!!